Manipulation of Spray-Drying Conditions to Develop an Inhalable Ivermectin Dry Powder

SARS-CoV-2, the causative agent of COVID-19, predominantly affects the respiratory tract. As a consequence, it seems intuitive to develop antiviral agents capable of targeting the virus right on its main anatomical site of replication. Ivermectin, a U.S. FDA-approved anti-parasitic drug, was origina...

Descripción completa

Detalles Bibliográficos
Autores principales: Saha, Tushar, Sinha, Shubhra, Harfoot, Rhodri, Quiñones-Mateu, Miguel E., Das, Shyamal C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325229/
https://www.ncbi.nlm.nih.gov/pubmed/35890327
http://dx.doi.org/10.3390/pharmaceutics14071432

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325229/
https://www.ncbi.nlm.nih.gov/pubmed/35890327
http://dx.doi.org/10.3390/pharmaceutics14071432

Ejemplares similares